<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02367092</url>
  </required_header>
  <id_info>
    <org_study_id>14-14783</org_study_id>
    <nct_id>NCT02367092</nct_id>
  </id_info>
  <brief_title>Exercise Intervention in Liver Transplant Patients</brief_title>
  <official_title>Exercise Intervention in Liver Transplant Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to learn more about the effects of exercise on functional status
      and outcomes on patients with end-stage liver disease on the liver transplant waiting list
      and who have undergone liver transplantation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aims to evaluate the effects of a home-based exercise intervention on outcomes in
      liver transplant candidates and recipients. This home-based intervention consists of a
      30-minute exercise session available on digital video disc or on the internet. This
      intervention was originally developed to improve functional status in community-dwelling
      older adults and therefore, has been designed to maximize the safety for even the most frail
      individuals. Subjects enrolled in this study will be randomized to one of two arms: (a) the
      exercise intervention arm in which the subjects will be asked perform this exercise session
      three to four times per week or (b) the standard-of-care arm in which the patient will be
      encouraged to exercise by their transplant clinician at every clinic visit. Subjects in the
      exercise intervention arm will undergo this intervention for 6 months. All subjects will be
      followed for up to two years from the time of enrollment to ascertain outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Liver Frailty Index</measure>
    <time_frame>12 and 24 weeks after enrollment</time_frame>
    <description>Liver Frailty Index as measured by score in functional assessments of grip strength (kg), balance (seconds), and chair stands (seconds).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality at 24 weeks</measure>
    <time_frame>1 year</time_frame>
    <description>Mortality status at 24 weeks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalized days at 24 weeks</measure>
    <time_frame>1 year</time_frame>
    <description>Number of days in the hospital from baseline to 24 weeks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>12 and 24 weeks after enrollment</time_frame>
    <description>Quality of life assessed by the CLDQ at 12 and 24 weeks after enrollment</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>End Stage Liver Disease</condition>
  <condition>Sarcopenia</condition>
  <condition>Liver Cirrhoses</condition>
  <arm_group>
    <arm_group_label>Exercise Program</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The exercise intervention consists of a 30 minute exercise session led by an instructor through a DVD or a video available on the internet.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard of care which consists of encouragement to exercise by the subject's transplant clinician.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise Program</intervention_name>
    <description>They will perform low-intensity, low-resistance exercise facilitated by a DVD video in their home. This exercise program lasts for 30 minutes at a time. Patients will be instructed to engage in this exercise program 3-4 times per week but not more often than 4 times per week. Pre-transplant patients will be asked to do the exercises from enrollment to transplant. Post-transplant patients will be asked to do the exercises for 6 months.</description>
    <arm_group_label>Exercise Program</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult (&gt;=18 years of age)

          -  Listed for liver transplantation or post-liver transplantation

          -  English speaking

        Exclusion Criteria:

          -  Contraindications to weight-bearing exercise

          -  Non-English speaking

          -  Requires an assistive device for ambulation

          -  Active hepatic encephalopathy at the time of baseline assessment for enrollment in the
             study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jennifer C Lai, MD, MBA</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jennifer C Lai, MD, MBA</last_name>
    <phone>415-476-2777</phone>
    <email>jennifer.lai@ucsf.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Adrienne Lebsack, MPH</last_name>
    <phone>415-476-3170</phone>
    <email>adrienne.lebsack@ucsf.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of California, San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Lai, MD, MBA</last_name>
      <phone>415-476-2777</phone>
      <email>jennifer.lai@ucsf.edu</email>
    </contact>
    <contact_backup>
      <last_name>Adrienne Lebsack, MPH, MAS</last_name>
      <phone>415-476-3170</phone>
      <email>adrienne.lebsack@ucsf.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Jennifer Lai, MD, MBA</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21218</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mara McAdams DeMarco, PhD</last_name>
      <email>mara@jhu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Malu Perez, DVM</last_name>
      <email>mmooney6@jhmi.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Duke University</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27708</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Kappus, MD</last_name>
      <email>matthew.kappus@duke.edu</email>
    </contact>
    <contact_backup>
      <last_name>Stacy Smith</last_name>
      <email>stacey.d.smith@duke.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.cdc.gov/nchs/faststats/liver-disease.htm</url>
    <description>National Center for Health Statistics</description>
  </link>
  <link>
    <url>http://optn.transplant.hrsa.gov</url>
    <description>United Network for Organ Sharing</description>
  </link>
  <reference>
    <citation>Murray KF, Carithers RL Jr; AASLD. AASLD practice guidelines: Evaluation of the patient for liver transplantation. Hepatology. 2005 Jun;41(6):1407-32.</citation>
    <PMID>15880505</PMID>
  </reference>
  <reference>
    <citation>Lai JC, Feng S, Terrault NA, Lizaola B, Hayssen H, Covinsky K. Frailty predicts waitlist mortality in liver transplant candidates. Am J Transplant. 2014 Aug;14(8):1870-9. doi: 10.1111/ajt.12762. Epub 2014 Jun 16.</citation>
    <PMID>24935609</PMID>
  </reference>
  <reference>
    <citation>Dasarathy S. Consilience in sarcopenia of cirrhosis. J Cachexia Sarcopenia Muscle. 2012 Dec;3(4):225-37. doi: 10.1007/s13539-012-0069-3. Epub 2012 May 31.</citation>
    <PMID>22648736</PMID>
  </reference>
  <reference>
    <citation>Jones JC, Coombes JS, Macdonald GA. Exercise capacity and muscle strength in patients with cirrhosis. Liver Transpl. 2012 Feb;18(2):146-51. doi: 10.1002/lt.22472. Review.</citation>
    <PMID>22139897</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 20, 2014</study_first_submitted>
  <study_first_submitted_qc>February 12, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 20, 2015</study_first_posted>
  <last_update_submitted>January 30, 2018</last_update_submitted>
  <last_update_submitted_qc>January 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Francisco</investigator_affiliation>
    <investigator_full_name>Jennifer Lai</investigator_full_name>
    <investigator_title>Assistant Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Liver Transplantation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Sarcopenia</mesh_term>
    <mesh_term>End Stage Liver Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

